
Module 6: Approach the Use of Medications Mindfully
Course Overview
This module explores Paradigm of Kindness with a focus on approaching medication use for infants and families affected by substance use disorder (SUD) in a mindful, compassionate, and evidence-based manner. Learners will review how to communicate medication decisions with families using trauma-informed, non-stigmatizing language, and understand the principles of medication-assisted treatment (MAT)/medications for opioid use disorder (MOUD) and safe prescribing for both mother and baby. The module emphasizes that medications are not a failure of non-pharmacologic care, but a supportive adjunct when needed, always paired with first-line nurturing interventions. Practical strategies for individualized medication use, PRN dosing, and protocols to keep mother and infant together are highlighted. By the end of this module, participants will be equipped to empower families, reduce stigma, and support recovery and healing through mindful medication practices.
Course Objectives
Identify how to discuss medication decisions with patients
Focusing on communication techniques that are compassionate, trauma-informed, and supportive of family engagement.Review the principles of medication assisted treatment (MAT)/ medications for opioid use disorder (MOUD) and safe prescribing for mom and baby
Emphasizing support of maternal recovery and infant health through safe, evidence-based medication practices. Emphasize that medications are not a failure of non-pharmacological care, but an adjunct to ESC when needed
Reinforcing that medication use is a supportive tool and should always be paired with non-pharmacologic care.
Target Audience
All clinical staff working with perinatal patients and infants.
Faculty
Rachael Duncan
Disclosure
Rachael Duncan discloses no such relationships exist
In compliance with the Essentials and Standards of the ACCME, the author of this CME tutorial is required to disclose any significant financial or other relationships they may have with commercial interests.
Date of Release
January 7th, 2026
Date of Most Recent Review
January 7th, 2026
Expiration Date
January 7th, 2029
Accreditation
This course has not been accredited for continuing medical education (CME).

